Skip to content

Using MRI in Patients With Non-dystrophic Myotonia to Access Muscle Contractility

Using MRI to Quantify Fatty Infiltration in Muscle Tissue, and Compare it to Isometric Muscle Strength Measurements and (2) Use Questionnaires, Systemic Interview and Simple Myotonic Bed-side Tests to Describe the Phenotype.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04808388
Enrollment
25
Registered
2021-03-22
Start date
2021-02-02
Completion date
2021-12-31
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nondystrophic Myotonia, Paramyotonia Congenita

Brief summary

The aim of this project is (1) to investigate whether or not structural muscle abnormalities could be a consequence of the disorder and (2) to provide further clinical description of this rare phenotype. To do so, the investigators will (1) use Dixon MRI to quantify fatty infiltration in muscle tissue and compare it to muscle strength measurements from isometric dynamometry in order to access contractility and (2) describe the myotonic phenotype with simple squeeze test and questionnaires.

Detailed description

Non-dystrophic myotonias are rare genetic diseases in which the membrane excitability is altered by mutations in genes encoding muscle ion channels. Patients suffer from myotonic stiffness, pain, fatigue and sometimes paralysis. Non-dystrophic myotonia is distinct from myotonic dystrophies with the absence of muscle degeneration. Paramyotonica congenita is characterzied by paradoxial myotonia, which, in contrast to the more common myotonia congenita, is myotonic stiffness that worsens with activity. Typically, the first few contractions seem normal, whereas repetition leads to severe stiffness. Our hypophysis is that these patient might also suffer from muscle degeneration.

Interventions

OTHERMRI

Using MRI for fat fraction and Biodex for isometric strength

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age * Diagnosed with non-dystrophic myotonia

Exclusion criteria

* MRI contraindications

Design outcomes

Primary

MeasureTime frameDescription
Contractile properties1 yearContractility = strength (kg) divided with cross sectional area of the muscle (CCSA)

Secondary

MeasureTime frameDescription
Muscle strength1 yearPeak torque (maximal contraction in kg) accessed from isometric dynamometry
Cross sectional area (CCSA)1 yearBy using MRI to visualize the muscle

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026